Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: The aim of the RAAS-COVID-19 randomized control trial is to evaluate whether an upfront strategy of temporary discontinuation of renin angiotensin aldosterone system (RAAS) inhibition versus continuation of RAAS inhibition among patients admitted with established COVID-19 infection has a...

Descripción completa

Detalles Bibliográficos

Autores principales:	Aflaki, Mona, Flannery, Alexandria, Ferreira, João Pedro, Cheng, Matthew Pellan, Kronfli, Nadine, Marelli, Ariane, Zannad, Faiez, Brophy, James, Afillalo, Jon, Huynh, Thao, Giannetti, Nadia, Bessissow, Amal, Ezekowitz, Justin A., Lopes, Renato D., Ambrosy, Andrew P., Craig, Morgan, Sharma, Abhinav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862851/ https://www.ncbi.nlm.nih.gov/pubmed/33546734 http://dx.doi.org/10.1186/s13063-021-05080-4